Keros Therapeutics (KROS) Return on Assets [ROA] (2020 - 2026)
Keros Therapeutics (KROS) recorded Return on Assets [ROA] of -28.82% in Q2 2026, down 31.25 percentage points from 2.44% a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics reported Return on Assets [ROA] of 18.24%, up 56.25 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of +50.60 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -38.01% in FY2024 (+7.20 pp), -45.21% in FY2023 (-7.96 pp), -37.25% in FY2022 (-14.86 pp) and -22.39% in FY2021 (+9.96 pp).
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] since Q4 2024.
- On a year-over-year basis, Return on Assets [ROA] rose in six of the last seven quarters, with an average year-over-year change of +24.11 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 47.45 percentage points in Q4 2025, against a drop of 31.25 percentage points in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.14% |
| 10 | Keros Therapeutics | 223.65 Mn | -1.71 Bn | - | -28.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.82% |
| Dec 31, 2025 | 16.10% |
| Sep 30, 2025 | 8.59% |
| Jun 30, 2025 | 2.44% |
| Mar 31, 2025 | 0.60% |
| Dec 31, 2024 | -31.35% |
| Sep 30, 2024 | -36.31% |
| Jun 30, 2024 | -37.86% |
| Mar 31, 2024 | -40.71% |
| Dec 31, 2023 | -48.81% |
| Sep 30, 2023 | -44.89% |
| Jun 30, 2023 | -36.03% |
| Mar 31, 2023 | -34.54% |
| Dec 31, 2022 | -37.43% |
| Sep 30, 2022 | -34.18% |
| Jun 30, 2022 | -34.08% |
| Mar 31, 2022 | -27.34% |
| Dec 31, 2021 | -24.21% |
| Sep 30, 2021 | -26.39% |
| Jun 30, 2021 | -21.64% |
API Access
Keros Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();